This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The findings were published in Clinical NuclearMedicine. The newly published study involved performing PETscans on 22 people with MS and eight healthy controls. Those being treated with low-efficacy treatments had more abnormalities on their PETscans, suggesting more microglial cell activation.
milla1cf Wed, 05/31/2023 - 20:52 May 31, 2023 — GE HealthCare announced US FDA 510(k) clearance of Precision DL – a new, revolutionary deep learning-based image processing software included in GE HealthCare’s growing Effortless Recon DL portfolio. iii] Based on orders data of GE HealthCarePET/CT systems since 2010. [iv]
For pharmaceutical companies and researchers, using this tracer to better understand the mechanism of action - i.e. the effect of immunotherapies on a patient’s immune response to their cancer - could, potentially, enable them to better select patients to participate in clinical trials and bring new immunotherapies to market. Fruhwirth, G.
Brain Tumor Spotted on PET Imaging An AI algorithm named “JuST_BrainPET” identified a glioblastoma in a patient that had been missed by physicians. This finding, reported in the Journal of NuclearMedicine, underscores the potential of AI-based decision support in diagnostic and treatment planning.
PACS works as a host that integrates the radiological images acquired from different radiological imaging modalities (X-Ray, Ultrasound, CT, MRI , PETScan, NuclearMedicine, etc…) with a network of information system (RIS and or HIS), EMR, different work stations and image storage/archival system.
PET has provided the first neuroimaging evidence that music affects the brains opioid receptor system, according to researchers in Finland. The study was published April 4 in the European Journal of NuclearMedicine and Molecular Imaging.
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PETscans predict patient response to Pluvicto.
Alzheimer’s has been a formidable challenge for our society, patients, caregivers, and healthcare systems for decades. Additionally, an increasing aging population has further exacerbated the burden of this disease on healthcare systems. Beyond coverage, improved payment policies can help increase access to PETscans as well.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content